Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,582 total articles
BioCryst (BCRX) is executing on a two-pillared strategy: scale ORLADEYO's profitable, growing U.S. business while adding navenibart, a long-acting monoclonal antibody, for patients who prefer infrequent dosing. Strong Q1 revenue, a $70M upfront licensing deal in Europe, recent conference data, and free cash flow generation create a favorable risk/r…
Zeta Global (ZETA) pulled back after a run into the 52-week high. The company's Athena AI platform and recent Marigold deal are fueling revenue acceleration while free cash flow and a conservative balance sheet limit downside. This trade idea lays out a mid-term long with clear entry, stop and target.
Figure Technology (FIGR) is a blockchain-native capital marketplace that is rapidly scaling loan origination, tokenization, and stablecoin funding. Recent Q1 results, strong monthly volumes, and the announced $717M Kiavi acquisition create a near-term revenue cadence and a multi-year margin opportunity. We outline a long trade that targets a re-rat…
Lynas is moving from spot-exposed pricing to a more contracted, fee-for-processing revenue mix. That structural shift should translate spot volatility into steadier cash flow over the next 6-12 months. This trade idea buys that transition while managing execution risk around operational ramps and geopolitical sensitivity.
Coda Octopus reported a quarter that looks fundamentally encouraging on several fronts (EPS, free cash flow, and enterprise metrics), but the stock has dumped hard on heavy intraday volume and elevated short activity. That creates a tradable setup: a tactical long entry near $9.60 with a $13.00 target over the next 45 trading days and a stop at $8.…
Instacart (Maplebear Inc., CART) is showing improving unit economics as take rates on advertising and fulfillment rise. The stock trades at a reasonable multiple relative to its free cash flow and profitability; we see a clear path for adjusted EBITDA expansion to re-rate the shares toward prior highs. This is a long trade: buy at $41.83, stop $37.…
Astronics looks set to benefit from rising aircraft production, a growing aircraft lighting market, and meaningful backlog conversion. The stock recently pulled back into technical support and offers a tactical long with defined risk management. This trade balances upside to prior highs around $96 with a disciplined stop below near-term structure.
Borr Drilling faces immediate downward pressure after a strategic investor began trimming a meaningful stake. The technical and liquidity dynamics favor a tactical short over the next several weeks. We present an entry at $1.25, stop at $1.65 and primary target at $0.85 for a focused short lasting roughly 10 trading days, with a secondary, deeper t…
Ondas (ONDS) just handed the market a clearer path to justify its rally: Q1 revenue of $50.1M and a raised 2026 revenue target above $390M turn an extreme trailing price-to-sales into a much more defendable forward multiple. The trade: buy a tactical swing while using tight risk control — the balance of strong top-line momentum, a growing defense b…
COPX offers direct, market-cap-weighted exposure to copper miners at a time when electrification, data-center build-outs and renewable infrastructure are increasing copper intensity. Technicals show the ETF trading above short- and medium-term moving averages, while macro and supply risks keep volatility high. This trade proposes a long position wi…
Cerence is executing the right financial moves at the right time: selective repurchases of cheap convertible debt reduce interest expense and dilution, while xUI adoption and new partnerships broaden addressable markets. At a market cap near $493M and an enterprise value of $544M, the stock looks positioned for a mid-to-late cycle rerate as operati…
Ondas (ONDS) just proved it can scale revenue fast: Q1 reported $50.1M and management raised 2026 revenue guidance above $390M. The market has punished the stock from recent highs; that pullback creates a tactical long opportunity for disciplined traders willing to accept high volatility. This is a swing trade that banks on continued order fulfillm…
Lumentum (LITE) has already run but the underlying demand drivers - hyperscaler AI buildouts and direct strategic support from Nvidia - suggest more runway. The valuation is rich, but revenue acceleration, a large market cap, and tight float/short dynamics create a tradeable long with defined risk limits.
Sea (SE) has traded sideways since its 52-week high but recent results show accelerating revenue and record adjusted EBITDA. With a market cap of ~$53.7B, robust cash and improving unit economics across e‑commerce and fintech, the stock is anchored near a logical floor. This trade idea recommends a long entry at the current market price, a discipli…
Nuvation Bio (NUVB) trades near $4.92 with a market cap around $1.72B and an enterprise value of roughly $1.64B. With six clinical-stage oncology programs and recent volatility tied to treatment-discontinuation disclosures and an investor lawsuit, the market has priced in execution risk. For traders willing to accept biotech binary risk, a mid-term…
Rocket Lab (RKLB) is benefiting from two immediate market forces: SpaceX's blockbuster Nasdaq debut and Rocket Lab's inclusion in the Nasdaq-100 effective 06/22/2026. That combo has exposed RKLB to fresh passive inflows and sector rotation. The company still carries growth/earnings execution risk, but with a $61.8B market cap, low leverage and a cl…
Advantest (ATEYY) is a global leader in semiconductor test systems whose recent price action and industry tailwinds present a favorable risk/reward from short- to long-term horizons. Valuation is rich by headline multiples, but earnings leverage from advanced packaging, AI-driven test demand, and expanding terahertz applications support further ups…
Generac has pivoted beyond home standby generators into becoming a core supplier of critical power for AI data centers. Recent results, a landmark hyperscaler supply agreement, and strong commercial growth make a long-biased trade attractive despite a premium valuation. This trade idea lays out entry, stop, and target with a long-term horizon and c…
Nvidia may enter a new growth phase in H2 2026 as product cycle timing, data-center refreshes, and AI model rollouts create a window for outsized upside. This is a tactical long trade sized for a medium risk appetite with a clear entry, target, and stop-loss tied to event cadence and technical support levels.
Cushman & Wakefield (CWK) trades at a modest enterprise multiple and very low P/S despite a recovery in transaction and services demand. The balance sheet, positive free cash flow, and technical setup argue for a pragmatic long trade. This idea targets a move back toward the 52-week high while protecting capital with a clearly defined stop.
Arm's lightweight, energy-efficient architecture is increasingly central to AI compute across edge and cloud. With a market cap near $406B and strong technical momentum, the stock looks like a justified long for investors who believe AI infrastructure spending will keep compounding. This trade balances a growth-forward thesis against rich multiples…
IBM looks positioned to convert government backing for quantum and a rising 'data gravity' trend into durable revenue growth. With strong free cash flow, a healthy dividend, and enterprise-grade hardware/software integration, IBM is a high-conviction long trade for investors willing to hold through execution for AI and quantum milestones.
Meta is trading at an accessible multiple relative to its cash flow and profitability despite heavy AI capex headlines. With a $1.49T market cap, >$48B in trailing free cash flow and a 29% ROE, this trade targets a recovery toward prior highs as AI investments mature and in-house chips start to show efficiency gains.
Novo Nordisk is trading well below its 52-week high despite a dominant position in GLP-1 therapies and fresh regulatory wins for an oral Wegovy tablet. The balance sheet, dividend yield, and a reasonable P/E provide a constructive backdrop. This trade idea proposes a long entry at $44.00 with a $60.00 target over the next 180 trading days and a sto…
Adobe (ADBE) plunged after leadership changes and AI-related angst, taking the stock to ~50% off its 52-week high. Fundamentals remain strong: $6.62B quarterly revenue growth, $10.3B in free cash flow and a sub-12x P/E. That combination argues for a tactical long with a clear entry, stop and target over a 46-180 trading day horizon.
